Clinical Trial Update: Bioequivalence Study [Phase 1]

View source ↗

Summary

AstraZeneca completed a Phase 1 bioequivalence study for a diabetes product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes | Phase 1 | Status: COMPLETED